Gilead's experimental HIV treatment shows low discontinuation rates in studies
|
The company studied the pill in HIV patients whose
virus was already suppressed, including those switching from complex
multi-tablet regimens or from ... |
New approach to HIV treatment offers hope to reduce daily drug needs
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...